Principia BioPharma
Latest round
- Series B
Last raised
- Jul 2015
Total raised
- $90M
Investors
- 6
About Principia BioPharma
Founded in 2008 and based in California, US, Principia BioPharma Inc. is a biopharmaceutical company that utilizes the Tailored Covalency platform to design and develop small molecules for oral therapies to treat patients with cancer, autoimmune and inflammatory diseases.
Who invested in Principia BioPharma
6 investors across 4 rounds
See all investors in Principia BioPharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Principia BioPharma
Who invested in Principia BioPharma?
Principia BioPharma has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Principia BioPharma raised?
Principia BioPharma has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Principia BioPharma last raise money?
Principia BioPharma's most recent round on record is a Series B, in Jul 2015.
What does Principia BioPharma do?
Founded in 2008 and based in California, US, Principia BioPharma Inc.
Where is Principia BioPharma headquartered?
Principia BioPharma is headquartered in South San Francisco, US.
Which VCs invest in companies like Principia BioPharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Principia BioPharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Principia BioPharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.